Gene: ARL11 ×
Source: BEFREE ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3803185
rs3803185
ARL11
0.030 GeneticVariation BEFREE Recently, we showed that homozygous carriers for the T442C variant of the ARLTS1 gene (ADP-ribosylation factor-like tumour suppressor protein 1 or ARL11, located at 13q14) are associated with an increased risk for both unselected and familial PCa. 23940804

2013
dbSNP: rs3803185
rs3803185
ARL11
0.030 GeneticVariation BEFREE Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells. 22028916

2011
dbSNP: rs3803185
rs3803185
ARL11
0.030 GeneticVariation BEFREE Our results suggest that Trp149Stop is not a predisposition allele in breast, prostate, or colorectal cancer in the Finnish population, and, while the Gly65Val variant may increase familial prostate cancer risk and the Cys148Arg change may affect both breast and prostate cancer risk, the evidence is not strong in these data. 18337727

2008
dbSNP: rs117251022
rs117251022
ARL11
0.010 GeneticVariation BEFREE Our results suggest that Trp149Stop is not a predisposition allele in breast, prostate, or colorectal cancer in the Finnish population, and, while the Gly65Val variant may increase familial prostate cancer risk and the Cys148Arg change may affect both breast and prostate cancer risk, the evidence is not strong in these data. 18337727

2008
dbSNP: rs34301344
rs34301344
ARL11
0.010 GeneticVariation BEFREE Our results suggest that Trp149Stop is not a predisposition allele in breast, prostate, or colorectal cancer in the Finnish population, and, while the Gly65Val variant may increase familial prostate cancer risk and the Cys148Arg change may affect both breast and prostate cancer risk, the evidence is not strong in these data. 18337727

2008
dbSNP: rs755100942
rs755100942
ARL11
0.010 GeneticVariation BEFREE Our results suggest that Trp149Stop is not a predisposition allele in breast, prostate, or colorectal cancer in the Finnish population, and, while the Gly65Val variant may increase familial prostate cancer risk and the Cys148Arg change may affect both breast and prostate cancer risk, the evidence is not strong in these data. 18337727

2008